Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion &

Updated 06/21/2024

Status Terminated

Clinical Trial Summary

The purpose of this research is to study the effects of 1,25(OH)2 D3 (a prescription form of active Vitamin D) on muscle strength and insulin secretion by the pancreas and glucose utilization by skeletal muscle.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04286529
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Terminated
Phase	Phase 1
Start date	October 1, 2020
Completion date	May 28, 2021

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01944904` - Investigation of the Ability of a Supplement to Increase Good Bacteria in the Human Intestine and Blood Sugar Levels	N/A
	Completed	`NCT02756117` - The Effect of Acute Lysine Administration on α-aminoadipic Acid	Phase 1
	Completed	`NCT02482922` - Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors	N/A
	Completed	`NCT01579292` - A Mobile Based Diabetes Prevention Program	N/A
	Recruiting	`NCT03495362` - The Effect of Insoluble Yeast Beta-glucan Intake on Pre-diabetic Patients	N/A
	Completed	`NCT03708419` - Personalized Glucose Optimization Through Nutritional Intervention	N/A
	Completed	`NCT02124590` - The Effect of Oral Carnitine Supplementation on MRS-derived Mitochondrial Function	N/A
	Completed	`NCT01411540` - Effects of a Wholegrain Diet on Body Composition and Energy Balance	N/A
	Suspended	`NCT03508739` - Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition	Phase 3
	Completed	`NCT01980017` - Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education Programs	N/A